Cargando…

On the Role of Illness Duration and Nutrient Restriction in Cholestatic Alterations that Occur During Critical Illness

BACKGROUND AND AIMS: Elevated markers of cholestasis are common in response to critical illness, and associated with adverse outcome. The role of illness duration and of nutrient restriction on underlying molecular pathways of such cholestatic responses have not been thoroughly investigated. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jenniskens, Marc, Güiza, Fabian, Oorts, Marlies, Vander Perre, Sarah, Derde, Sarah, Dufour, Thomas, Thiessen, Steven, Annaert, Pieter, Van den Berghe, Greet, Langouche, Lies
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Basic Science Aspects
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039378/ https://www.ncbi.nlm.nih.gov/pubmed/29076974 http://dx.doi.org/10.1097/SHK.0000000000001001

Ejemplares similares

Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages
por: Marques, Mirna Bastos, et al.
Publicado: (2013)

Premorbid obesity, but not nutrition, prevents critical illness‐induced muscle wasting and weakness
por: Goossens, Chloë, et al.
Publicado: (2016)

Efficacy and safety of ketone ester infusion to prevent muscle weakness in a mouse model of sepsis-induced critical illness
por: Weckx, Ruben, et al.
Publicado: (2022)

SUN-548 Ketone Bodies in Critical Illness Alter Cholesterol Synthesis in Skeletal Muscle, Interlinked with Protection Against Weakness
por: Goossens, Chloë, et al.
Publicado: (2020)

Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages
por: Marques, M, et al.
Publicado: (2013)

Proliferation and differentiation of adipose tissue in prolonged lean and obese critically ill patients
por: Goossens, Chloë, et al.
Publicado: (2017)

Critical illness induces alternative activation of M2 macrophages in adipose tissue
por: Langouche, Lies, et al.
Publicado: (2011)

OR19-06 Sepsis-Induced Critical Illness in Mice Alters Key Regulators of ACTH Production and Secretion Within the Anterior Pituitary Gland
por: Téblick, Arno, et al.
Publicado: (2020)

Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate
por: Goossens, Chloë, et al.
Publicado: (2021)

Prevalence and Prognostic Value of Abnormal Liver Test Results in Critically Ill Children and the Impact of Delaying Parenteral Nutrition*
por: Jenniskens, Marc, et al.
Publicado: (2018)

Impact of withholding early parenteral nutrition in adult critically ill patients on ketogenesis in relation to outcome
por: De Bruyn, Astrid, et al.
Publicado: (2021)

Adipose tissue protects against sepsis-induced muscle weakness in mice: from lipolysis to ketones
por: Goossens, Chloë, et al.
Publicado: (2019)

OR20-6 Ketones and Sepsis-Induced Muscle Weakness: Signal or Fuel for Protection?
por: Weckx, Ruben, et al.
Publicado: (2019)

Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin
por: Langouche, Lies, et al.
Publicado: (2009)

Impact of tight glucose control on circulating 3-hydroxybutyrate in critically ill patients
por: Gunst, Jan, et al.
Publicado: (2021)

The role of pro-opiomelanocortin in the ACTH–cortisol dissociation of sepsis
por: Téblick, Arno, et al.
Publicado: (2021)

The Role of Autophagy in Critical Illness-induced Liver Damage
por: Thiessen, Steven E., et al.
Publicado: (2017)

Nonthyroidal Illness Syndrome Across the Ages
por: Langouche, Lies, et al.
Publicado: (2019)

Obesity attenuates inflammation, protein catabolism, dyslipidaemia, and muscle weakness during sepsis, independent of leptin
por: Vankrunkelsven, Wouter, et al.
Publicado: (2022)

Impact of Hydrocortisone and of CRH Infusion on the Hypothalamus-Pituitary-Adrenocortical Axis of Septic Male Mice
por: Téblick, Arno, et al.
Publicado: (2021)

ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study
por: Peeters, Bram, et al.
Publicado: (2018)

OR26-4 Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
por: Téblick, Arno, et al.
Publicado: (2022)

Anterior pituitary function in critical illness
por: Téblick, Arno, et al.
Publicado: (2019)

Identification of the toxic threshold of 3-hydroxybutyrate-sodium supplementation in septic mice
por: Weckx, Ruben, et al.
Publicado: (2021)

Development of muscle weakness in a mouse model of critical illness: does fibroblast growth factor 21 play a role?
por: Vankrunkelsven, Wouter, et al.
Publicado: (2023)

Adrenocortical function during prolonged critical illness and beyond: a prospective observational study
por: Peeters, Bram, et al.
Publicado: (2018)

Expression of glucose transporters in critical illness
por: Langouche, L, et al.
Publicado: (2006)

Hyperglycemia and insulin resistance in COVID-19 versus non-COVID critical illness: Are they really different?
por: Langouche, Lies, et al.
Publicado: (2021)

The Hypothalamus-pituitary-adrenocortical Response to Critical Illness: A Concept in Need of Revision
por: Langouche, Lies, et al.
Publicado: (2023)

Alterations in adipose tissue during critical illness: an adaptive and protective response?
por: Langouche, L, et al.
Publicado: (2010)

Insulin signaling in critical illness: intensive versus conventional insulin therapy
por: Langouche, L, et al.
Publicado: (2005)

Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness
por: Mebis, Liese, et al.
Publicado: (2009)

The hypothalamus-pituitary-adrenal axis in sepsis- and hyperinflammation-induced critical illness: Gaps in current knowledge and future translational research directions
por: Van den Berghe, Greet, et al.
Publicado: (2022)

Impact of duration of critical illness and level of systemic glucocorticoid availability on tissue-specific glucocorticoid receptor expression and actions: A prospective, observational, cross-sectional human and two translational mouse studies
por: Téblick, Arno, et al.
Publicado: (2022)

Skeletal Muscle Myokine Expression in Critical Illness, Association With Outcome and Impact of Therapeutic Interventions
por: Vanhorebeek, Ilse, et al.
Publicado: (2023)

DNA methylation alterations in muscle of critically ill patients
por: Van Dyck, Lisa, et al.
Publicado: (2022)

Cardiac Troponin Release is Associated with Biomarkers of Inflammation and Ventricular Dilatation During Critical Illness
por: Ostermann, Marlies, et al.
Publicado: (2017)

Promising avenues of therapeutics for bipolar illness
por: Post, Robert M.
Publicado: (2008)

OR17-1 Changes in the Hypothalamic-Pituitary-Adrenal Axis during Pediatric Critical Illness
por: Jacobs, An, et al.
Publicado: (2019)

SAT-155 Temporal Activation of the Unfolded Protein Response and Concomitant Downregulation of Key Hepatic Transcription Factors in Critical Illness
por: Vankrunkelsven, Wouter, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gstsasrmpg637tp94fe027mk0c